Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 324

1.

Reduced Activity of GGPPS Mutant is Involved in Bisphosphonates-Induced Atypical Fractures.

Lisnyansky M, Kapelushnik N, Ben-Bassat A, Marom M, Loewenstein A, Khananshvili D, Giladi M, Haitin Y.

Mol Pharmacol. 2018 Oct 1. pii: mol.118.113670. doi: 10.1124/mol.118.113670. [Epub ahead of print]

2.

Pharmacotherapeutic management of macular edema in diabetic subjects undergoing cataract surgery.

Sarao V, Veritti D, Maurutto E, Rassu N, Borrelli E, Loewenstein A, Sadda S, Lanzetta P.

Expert Opin Pharmacother. 2018 Sep 5:1-13. doi: 10.1080/14656566.2018.1516206. [Epub ahead of print]

PMID:
30185069
3.

Disorganization of Retinal Inner Layers as a Biomarker for Idiopathic Epiretinal Membrane After Macular Surgery - The DREAM Study.

Zur D, Iglicki M, Feldinger L, Schwartz S, Goldstein M, Loewenstein A, Barak A.

Am J Ophthalmol. 2018 Sep 1. pii: S0002-9394(18)30498-7. doi: 10.1016/j.ajo.2018.08.037. [Epub ahead of print]

PMID:
30179599
4.

Noninfectious Inflammatory Response following Intravitreal Bevacizumab Injections: Description of a Cluster of Cases in Two Centers and a Review of the Literature.

Trivizki O, Schwartz S, Negri N, Loewenstein A, Rabina G, Shulman S.

Ophthalmologica. 2018;240(3):163-166. doi: 10.1159/000492681. Epub 2018 Aug 31. Review.

PMID:
30173220
5.

Reply.

Zur D, Iglicki M, Busch C, Lupidi M, Loewenstein A.

Ophthalmology. 2018 Sep;125(9):e61-e62. doi: 10.1016/j.ophtha.2018.03.025. Epub 2018 Aug 21. No abstract available.

PMID:
30143101
6.

MULTIMODAL IMAGING OF CHOROIDAL AND OPTIC DISK VESSELS NEAR OPTIC DISK PITS.

Adams MK, Cohen SY, Souied EH, Goldenberg D, Loewenstein A, Olsen TW, Pulido JS.

Retin Cases Brief Rep. 2018 Jul 24. doi: 10.1097/ICB.0000000000000765. [Epub ahead of print]

PMID:
30045152
7.

UNDERDIAGNOSED OPTIC DISK PIT MACULOPATHY: Spectral Domain Optical Coherence Tomography Features For Accurate Diagnosis.

Iglicki M, Busch C, Loewenstein A, Fung AT, Invernizzi A, Mariussi M, Arias R, Gabrielle PH, Cebeci Z, Okada M, Nawrocki J, Michalewska Z, Goldstein M, Barak A, Zur D.

Retina. 2018 Jul 24. doi: 10.1097/IAE.0000000000002270. [Epub ahead of print]

PMID:
30045135
8.

Biomarkers and predictors for functional and anatomic outcomes for small gauge pars plana vitrectomy and peeling of the internal limiting membrane in naïve diabetic macular edema: The VITAL Study.

Iglicki M, Lavaque A, Ozimek M, Negri HP, Okada M, Chhablani J, Busch C, Loewenstein A, Zur D.

PLoS One. 2018 Jul 11;13(7):e0200365. doi: 10.1371/journal.pone.0200365. eCollection 2018.

9.

Long-term visual outcome and its predictors in macular oedema secondary to retinal vein occlusion treated with dexamethasone implant.

Busch C, Rehak M, Sarvariya C, Zur D, Iglicki M, Lima LH, Invernizzi A, Viola F, Agrawal K, Sinawat S, Couturier A, Mehta A, Juneja R, Jain H, Agarwal AK, Goel N, Nagpal M, Gupta V, Banker A, Loewenstein A, Okada M, Saatci AO, Mansour AM, Chhablani J.

Br J Ophthalmol. 2018 Jun 11. pii: bjophthalmol-2017-311805. doi: 10.1136/bjophthalmol-2017-311805. [Epub ahead of print]

PMID:
29891733
10.

Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema.

Busch C, Zur D, Fraser-Bell S, Laíns I, Santos AR, Lupidi M, Cagini C, Gabrielle PH, Couturier A, Mané-Tauty V, Giancipoli E, Ricci GD, Cebeci Z, Rodríguez-Valdés PJ, Chaikitmongkol V, Amphornphruet A, Hindi I, Agrawal K, Chhablani J, Loewenstein A, Iglicki M, Rehak M; International Retina Group.

Acta Diabetol. 2018 Aug;55(8):789-796. doi: 10.1007/s00592-018-1151-x. Epub 2018 May 5.

PMID:
29730822
11.

DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study.

Iglicki M, Busch C, Zur D, Okada M, Mariussi M, Chhablani JK, Cebeci Z, Fraser-Bell S, Chaikitmongkol V, Couturier A, Giancipoli E, Lupidi M, Rodríguez-Valdés PJ, Rehak M, Fung AT, Goldstein M, Loewenstein A.

Retina. 2018 Apr 24. doi: 10.1097/IAE.0000000000002196. [Epub ahead of print]

PMID:
29697589
12.

Prevalence of choroidal nevus and retinal pigment epithelial alterations in vitiligo patients.

Fleissig E, Pavlovksy M, Loewenstein A, Zur D, Newman H, Keren S, Goldenberg D, Bar-Ilan E, Goldstein M.

Graefes Arch Clin Exp Ophthalmol. 2018 May;256(5):927-933. doi: 10.1007/s00417-018-3958-0. Epub 2018 Mar 16.

PMID:
29549426
13.

Progression of diabetic retinopathy severity after treatment with dexamethasone implant: a 24-month cohort study the 'DR-Pro-DEX Study'.

Iglicki M, Zur D, Busch C, Okada M, Loewenstein A.

Acta Diabetol. 2018 Jun;55(6):541-547. doi: 10.1007/s00592-018-1117-z. Epub 2018 Mar 1.

PMID:
29497837
14.

ASSOCIATION BETWEEN EARLY ANATOMIC RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND LONG-TERM OUTCOME IN DIABETIC MACULAR EDEMA: AN INDEPENDENT ANALYSIS OF PROTOCOL I STUDY DATA.

Dugel PU, Campbell JH, Kiss S, Loewenstein A, Shih V, Xu X, Holekamp NM, Augustin AJ, Ho AC, Gonzalez VH, Whitcup SM.

Retina. 2018 Feb 22. doi: 10.1097/IAE.0000000000002110. [Epub ahead of print]

PMID:
29474302
15.

2018 Update on Intravitreal Injections: Euretina Expert Consensus Recommendations.

Grzybowski A, Told R, Sacu S, Bandello F, Moisseiev E, Loewenstein A, Schmidt-Erfurth U; Euretina Board.

Ophthalmologica. 2018;239(4):181-193. doi: 10.1159/000486145. Epub 2018 Feb 1. Review.

16.

The Management of Retinal Detachment: Techniques and Perspectives.

Moisseiev E, Loewenstein A, Moshiri A, Yiu G.

J Ophthalmol. 2017;2017:5807653. doi: 10.1155/2017/5807653. Epub 2017 Oct 23. No abstract available.

17.

OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.

Zur D, Iglicki M, Busch C, Invernizzi A, Mariussi M, Loewenstein A; International Retina Group.

Ophthalmology. 2018 Feb;125(2):267-275. doi: 10.1016/j.ophtha.2017.08.031. Epub 2017 Sep 19.

PMID:
28935399
18.

The relation of somatotypes and stress response to central serous chorioretinopathy.

Schwartz R, Rozenberg A, Loewenstein A, Goldstein M.

Graefes Arch Clin Exp Ophthalmol. 2017 Dec;255(12):2307-2315. doi: 10.1007/s00417-017-3787-6. Epub 2017 Sep 5.

PMID:
28875245
19.

Infliximab exerts a dose-dependent effect on retinal safety in the albino rabbit.

Zayit-Soudry S, Vainer I, Zemel E, Mimouni M, Rabena M, Pieramici DJ, Perlman I, Loewenstein A.

Doc Ophthalmol. 2017 Dec;135(3):175-185. doi: 10.1007/s10633-017-9606-x. Epub 2017 Aug 19.

PMID:
28825191
20.

Overexpression and Purification of Human Cis-prenyltransferase in Escherichia coli.

Edri I, Goldenberg M, Lisnyansky M, Strulovich R, Newman H, Loewenstein A, Khananshvili D, Giladi M, Haitin Y.

J Vis Exp. 2017 Aug 3;(126). doi: 10.3791/56430.

PMID:
28809830
21.

Safety of intravitreal clindamycin in albino rabbit eyes.

Habot-Wilner Z, Mazza O, Shahar J, Massarweh A, Mann I, Loewenstein A, Perlman I.

Doc Ophthalmol. 2017 Oct;135(2):133-146. doi: 10.1007/s10633-017-9599-5. Epub 2017 Jul 25.

PMID:
28744691
22.

Eplerenone for chronic central serous chorioretinopathy-a randomized controlled prospective study.

Schwartz R, Habot-Wilner Z, Martinez MR, Nutman A, Goldenberg D, Cohen S, Shulman S, Guzner-Gur H, Loewenstein A, Goldstein M.

Acta Ophthalmol. 2017 Nov;95(7):e610-e618. doi: 10.1111/aos.13491. Epub 2017 Jun 27.

PMID:
28653813
23.

A Review of Innovations in Rhegmatogenous Retinal Detachment Surgical Techniques.

Nemet A, Moshiri A, Yiu G, Loewenstein A, Moisseiev E.

J Ophthalmol. 2017;2017:4310643. doi: 10.1155/2017/4310643. Epub 2017 May 7. Review.

24.

[PRESENTATION OF OCULAR PROBLEMS AMONG DISPLACED PERSONS FROM SUDAN AND ERITREA AT THE TEL AVIV MEDICAL CENTER].

Schwartz R, Goldstein M, Loewenstein A, Barak A.

Harefuah. 2017 Jan;156(1):19-21. Hebrew.

PMID:
28530314
25.

Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti-vascular endothelial growth factor therapy of macular diseases.

Lanzetta P, Loewenstein A; Vision Academy Steering Committee.

Graefes Arch Clin Exp Ophthalmol. 2017 Jul;255(7):1259-1273. doi: 10.1007/s00417-017-3647-4. Epub 2017 May 19. Review.

26.

Diabetic Macular Edema: Emerging Strategies and Treatment Algorithms.

Moisseiev E, Loewenstein A.

Dev Ophthalmol. 2017;60:165-174. doi: 10.1159/000459706. Epub 2017 Apr 20. Review.

PMID:
28427075
27.

Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA).

Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, Berg K, Chakravarthy U, Gerendas BS, Jonas J, Larsen M, Tadayoni R, Loewenstein A.

Ophthalmologica. 2017;237(4):185-222. doi: 10.1159/000458539. Epub 2017 Apr 20. Review.

28.

Massive subretinal and subretinal pigment epithelial hemorrhage displacement with perfluorocarbon liquid using a two-step vitrectomy technique.

Fleissig E, Barak A, Goldstein M, Loewenstein A, Schwartz S.

Graefes Arch Clin Exp Ophthalmol. 2017 Jul;255(7):1341-1347. doi: 10.1007/s00417-017-3648-3. Epub 2017 Apr 15.

PMID:
28412773
29.

Drug Delivery to the Posterior Segment of the Eye.

Moisseiev E, Loewenstein A.

Dev Ophthalmol. 2017;58:87-101. doi: 10.1159/000455276. Epub 2017 Mar 28. Review.

PMID:
28351054
30.

Diabetic Macular Edema.

Bandello F, Battaglia Parodi M, Lanzetta P, Loewenstein A, Massin P, Menchini F, Veritti D.

Dev Ophthalmol. 2017;58:102-138. doi: 10.1159/000455277. Epub 2017 Mar 28. Review.

PMID:
28351052
31.

Postsurgical Cystoid Macular Edema.

Zur D, Loewenstein A.

Dev Ophthalmol. 2017;58:178-190. doi: 10.1159/000455280. Epub 2017 Mar 28. Review.

PMID:
28351047
32.

Reply.

Gonzalez VH, Campbell J, Holekamp NM, Kiss S, Loewenstein A, Augustin AJ, Ma J, Ho AC, Patel V, Whitcup SM, Dugel PU.

Am J Ophthalmol. 2017 May;177:231-232. doi: 10.1016/j.ajo.2017.02.009. Epub 2017 Mar 23. No abstract available.

PMID:
28342529
33.

Management of Diabetic Macular Edema.

Moisseiev E, Loewenstein A.

Ophthalmic Res. 2017;58(1):15-17. doi: 10.1159/000458535. Epub 2017 Mar 14. Review.

PMID:
28288460
34.

Purification and characterization of human dehydrodolychil diphosphate synthase (DHDDS) overexpressed in E. coli.

Giladi M, Edri I, Goldenberg M, Newman H, Strulovich R, Khananshvili D, Haitin Y, Loewenstein A.

Protein Expr Purif. 2017 Apr;132:138-142. doi: 10.1016/j.pep.2017.02.001. Epub 2017 Feb 3.

PMID:
28167250
35.

Macular Hole Surgery with Internal Limiting Membrane Peeling Facilitated by Membrane-Blue® versus Membrane-Blue-Dual®: A Retrospective Comparative Study.

Soiberman U, Shai D, Loewenstein A, Barak A.

J Ophthalmol. 2016;2016:1292735. doi: 10.1155/2016/1292735. Epub 2016 Dec 5.

36.

Early detection of age related macular degeneration: current status.

Schwartz R, Loewenstein A.

Int J Retina Vitreous. 2015 Dec 1;1:20. doi: 10.1186/s40942-015-0022-7. eCollection 2015. Review.

37.

Early and Long-Term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data.

Gonzalez VH, Campbell J, Holekamp NM, Kiss S, Loewenstein A, Augustin AJ, Ma J, Ho AC, Patel V, Whitcup SM, Dugel PU.

Am J Ophthalmol. 2016 Dec;172:72-79. doi: 10.1016/j.ajo.2016.09.012. Epub 2016 Sep 17.

38.

A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.

Callanan DG, Loewenstein A, Patel SS, Massin P, Corcóstegui B, Li XY, Jiao J, Hashad Y, Whitcup SM.

Graefes Arch Clin Exp Ophthalmol. 2017 Mar;255(3):463-473. doi: 10.1007/s00417-016-3472-1. Epub 2016 Sep 8.

PMID:
27632215
39.

Baseline Characteristics of the Fellow Eye in Patients with Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the VIEW Studies.

Wolf S, Bandello F, Loewenstein A, Slakter J, Katz T, Sowade O, Korobelnik JF.

Ophthalmologica. 2016;236(2):95-9. doi: 10.1159/000447725. Epub 2016 Jul 23.

40.

Automated Identification of Lesion Activity in Neovascular Age-Related Macular Degeneration.

Chakravarthy U, Goldenberg D, Young G, Havilio M, Rafaeli O, Benyamini G, Loewenstein A.

Ophthalmology. 2016 Aug;123(8):1731-1736. doi: 10.1016/j.ophtha.2016.04.005. Epub 2016 May 17.

PMID:
27206840
41.

Vascularization of Irregular Retinal Pigment Epithelial Detachments in Chronic Central Serous Chorioretinopathy Evaluated With OCT Angiography.

de Carlo TE, Rosenblatt A, Goldstein M, Baumal CR, Loewenstein A, Duker JS.

Ophthalmic Surg Lasers Imaging Retina. 2016 Feb;47(2):128-33. doi: 10.3928/23258160-20160126-05.

PMID:
26878445
42.

The suprachoroidal space: from potential space to a space with potential.

Moisseiev E, Loewenstein A, Yiu G.

Clin Ophthalmol. 2016 Jan 25;10:173-8. doi: 10.2147/OPTH.S89784. eCollection 2016.

43.

Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study.

Augustin AJ, Kuppermann BD, Lanzetta P, Loewenstein A, Li XY, Cui H, Hashad Y, Whitcup SM; Ozurdex MEAD Study Group.

BMC Ophthalmol. 2015 Oct 30;15:150. doi: 10.1186/s12886-015-0148-2.

44.

Therapeutic Monoclonal Antibodies and Fragments: Bevacizumab.

Klein A, Loewenstein A.

Dev Ophthalmol. 2016;55:232-45. doi: 10.1159/000431199. Epub 2015 Oct 26. Review.

PMID:
26502311
45.

Synthesis and Stereochemical Assignment of Crypto-Optically Active (2) H6 -Neopentane.

Masarwa A, Gerbig D, Oskar L, Loewenstein A, Reisenauer HP, Lesot P, Schreiner PR, Marek I.

Angew Chem Int Ed Engl. 2015 Oct 26;54(44):13106-9. doi: 10.1002/anie.201505349. Epub 2015 Sep 7.

PMID:
26480341
46.

INTRAVITREAL CORTICOSTEROIDS IN DIABETIC MACULAR EDEMA: PHARMACOKINETIC CONSIDERATIONS.

Yang Y, Bailey C, Loewenstein A, Massin P.

Retina. 2015 Dec;35(12):2440-9. doi: 10.1097/IAE.0000000000000726. Review.

47.

Power-Assisted Liposuction Versus Tissue Resection for the Isolation of Adipose Tissue-Derived Mesenchymal Stem Cells: Phenotype, Senescence, and Multipotency at Advanced Passages.

Barzelay A, Levy R, Kohn E, Sella M, Shani N, Meilik B, Entin-Meer M, Gur E, Loewenstein A, Barak A.

Aesthet Surg J. 2015 Sep;35(7):NP230-40. doi: 10.1093/asj/sjv055.

PMID:
26319084
48.

Optical Density of Subretinal Fluid in Retinal Detachment.

Leshno A, Barak A, Loewenstein A, Weinberg A, Neudorfer M.

Invest Ophthalmol Vis Sci. 2015 Aug;56(9):5432-8. doi: 10.1167/iovs.15-16952.

PMID:
26284548
49.

Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up. (BERVOLT study: Bevacizumab for RVO long-term follow-up).

Kornhauser T, Schwartz R, Goldstein M, Neudorfer M, Loewenstein A, Barak A.

Graefes Arch Clin Exp Ophthalmol. 2016 May;254(5):835-44. doi: 10.1007/s00417-015-3130-z. Epub 2015 Aug 14.

PMID:
26269374
50.

Optic disc pit maculopathy: when and how to treat? A review of the pathogenesis and treatment options.

Moisseiev E, Moisseiev J, Loewenstein A.

Int J Retina Vitreous. 2015 Aug 7;1:13. eCollection 2015. Review.

Supplemental Content

Loading ...
Support Center